Keeping with this weeks theme highlighting Washington's burdensome regulatory regime, this instance is one where the FDA could end up inhibiting medical research progress by establishing roadblocks to outpatient clinical trials of an artificial pancreas for people with type 1 diabetes.
On December 1, the FDA will issue crucial guidelines to the clinical trial that could result in obstacles being placed before researchers, scientists, and manufacturers.
The Juvenile Diabetes Research Foundation is asking that everyone take just 30 seconds to fill out their petition telling the FDA that delays to the outpatient clinical trials for an artificial pancreas are unacceptable.
Please take a moment to fill out their petition to help the health and even save the lives of children and families with type 1 diabetes today!
Print 
PDF